SITC Resource Library

Presentation slides and video from the 2023 Advances in Cancer Immunotherapy^™ Series: A Focus on Cellular Therapies and T Cell Engagers were presented live in Washington, D.C. and virtually on August 17, 2023.

Program Organizers

• Lekha Mikkilineni, MD – Stanford University
• Nirali N. Shah, MD, MHSc – National Cancer Institute, National Institutes of Health
• Bonnie Yates, MSN, CPNP-AC – National Institutes of Health

Target Audience

The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.

Program Learning Objectives

• Describe the mechanisms of cell therapies and T cell engagers.
• Summarize recent updates in the use of cell therapies and T cell engagers clinically.
• Outline common toxicities with cell therapies and T cell engagers and their management.
• Identify unique institutional resources required for the appropriate use of cell therapies.

You can view the program agenda here.

Please note on-demand recordings are not available for continuing education credits.